Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ALPELISIB Cause C-reactive protein increased? 14 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 14 reports of C-reactive protein increased have been filed in association with ALPELISIB (PIQRAY). This represents 0.2% of all adverse event reports for ALPELISIB.

14
Reports of C-reactive protein increased with ALPELISIB
0.2%
of all ALPELISIB reports
2
Deaths
11
Hospitalizations

How Dangerous Is C-reactive protein increased From ALPELISIB?

Of the 14 reports, 2 (14.3%) resulted in death, 11 (78.6%) required hospitalization, and 1 (7.1%) were considered life-threatening.

Is C-reactive protein increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ALPELISIB. However, 14 reports have been filed with the FAERS database.

What Other Side Effects Does ALPELISIB Cause?

Hyperglycaemia (1,575) Rash (1,393) Diarrhoea (1,336) Blood glucose increased (1,105) Death (921) Nausea (860) Fatigue (817) Decreased appetite (546) Weight decreased (508) Malignant neoplasm progression (497)

What Other Drugs Cause C-reactive protein increased?

METHOTREXATE (5,999) ADALIMUMAB (4,579) RITUXIMAB (4,060) ETANERCEPT (3,922) TOCILIZUMAB (3,719) INFLIXIMAB (3,621) LEFLUNOMIDE (3,574) HYDROXYCHLOROQUINE (3,552) ABATACEPT (3,451) SULFASALAZINE (3,096)

Which ALPELISIB Alternatives Have Lower C-reactive protein increased Risk?

ALPELISIB vs ALPHA.-LIPOIC ACID ALPELISIB vs ALPHA.-TOCOPHEROL ALPELISIB vs ALPHA.-TOCOPHEROL, D- ALPELISIB vs ALPHA.-TOCOPHEROL, DL- ALPELISIB vs ALPHA.1-PROTEINASE INHIBITOR HUMAN

Related Pages

ALPELISIB Full Profile All C-reactive protein increased Reports All Drugs Causing C-reactive protein increased ALPELISIB Demographics